Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030

Report
187 Pages
March 2024
Region: Global
360iResearch™
ID: 4807792

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Specialty Pharmaceuticals Market size was estimated at USD 92.50 billion in 2023, USD 129.23 billion in 2024, and is expected to grow at a CAGR of 39.80% to reach USD 965.54 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Specialty Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Specialty Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Specialty Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Bristol Myers Squibb Company, Endo International PLC, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Hyphens Pharma International Limited, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., UnitedHealth Group, and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Specialty Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- CNS
- Infectious Diseases
- Oncology
- Respiratory
- Women’s Health
Product
- Oral Pharmaceuticals
- Parenteral Pharmaceuticals
- Transdermal Pharmaceuticals
Distribution Channel
- Hospitals & Care Providers
- Online Mode
- Retail Pharmacies
- Specialty Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Specialty Pharmaceuticals Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Specialty Pharmaceuticals Market?
What are the technology trends and regulatory frameworks in the Specialty Pharmaceuticals Market?
What is the market share of the leading vendors in the Specialty Pharmaceuticals Market?
Which modes and strategic moves are suitable for entering the Specialty Pharmaceuticals Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Specialty Pharmaceuticals Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
5.1.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
5.1.1.3. Attractive prospects for pharmaceutical companies from both business and medical innovation perspective
5.1.2. Restraints
5.1.2.1. Cost sharing discourages the use leading to adverse health outcomes
5.1.3. Opportunities
5.1.3.1. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
5.1.3.2. Growth of enhanced information technologies in the specialty pharmaceuticals sector
5.1.4. Challenges
5.1.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Regulatory Framework
5.10.2. Value Chain Analysis
5.10.3. Patent Analysis and Trend

6. Specialty Pharmaceuticals Market, by Type

6.1. Introduction
6.2. CNS
6.3. Infectious Diseases
6.4. Oncology
6.5. Respiratory
6.6. Women’s Health

7. Specialty Pharmaceuticals Market, by Product

7.1. Introduction
7.2. Oral Pharmaceuticals
7.3. Parenteral Pharmaceuticals
7.4. Transdermal Pharmaceuticals

8. Specialty Pharmaceuticals Market, by Distribution Channel

8.1. Introduction
8.2. Hospitals & Care Providers
8.3. Online Mode
8.4. Retail Pharmacies
8.5. Specialty Pharmacies

9. Americas Specialty Pharmaceuticals Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Specialty Pharmaceuticals Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Specialty Pharmaceuticals Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Amgen Inc.
13.1.3. Bristol Myers Squibb Company
13.1.4. Endo International PLC
13.1.5. F. Hoffmann-La Roche Ltd.
13.1.6. Gilead Sciences, Inc.
13.1.7. Hyphens Pharma International Limited
13.1.8. Merck KGaA
13.1.9. Novartis AG
13.1.10. Pfizer Inc.
13.1.11. Sanofi S.A.
13.1.12. Teva Pharmaceutical Industries Ltd.
13.1.13. UnitedHealth Group
13.1.14. Viatris Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. SPECIALTY PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. SPECIALTY PHARMACEUTICALS MARKET SIZE, 2022 VS 2030
FIGURE 3. SPECIALTY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SPECIALTY PHARMACEUTICALS MARKET DYNAMICS
FIGURE 7. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 12. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. SPECIALTY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. SPECIALTY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. SPECIALTY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. SPECIALTY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. EGYPT SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FINLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. NORWAY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. POLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. POLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. TURKEY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. SPECIALTY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 148. SPECIALTY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 149. SPECIALTY PHARMACEUTICALS MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Amgen Inc.
Bristol Myers Squibb Company
Endo International PLC
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
Hyphens Pharma International Limited
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
UnitedHealth Group
Viatris Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	187
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 129.23 Billion
Forecasted Market Value ( USD ) by 2030	$ 965.54 Billion
Compound Annual Growth Rate	39.8%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Specialty Pharmaceutical Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Global Specialty Pharmaceuticals Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Specialty Pharmaceuticals Market 2023-2027

Global Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Forecast 2023-2030

About the Specialty Pharmaceutical Market